Litigation Details for Javelin Pharmaceuticals, Inc. v. Mylan Laboratories Limited (D. Del. 2016)
✉ Email this page to a colleague
Javelin Pharmaceuticals, Inc. v. Mylan Laboratories Limited (D. Del. 2016)
Docket | ⤷ Try a Trial | Date Filed | 2016-04-04 |
Court | District Court, D. Delaware | Date Terminated | 2017-12-17 |
Cause | 35:271 Patent Infringement | Assigned To | Leonard Philip Stark |
Jury Demand | None | Referred To | |
Parties | HOSPIRA, INC. | ||
Patents | 6,407,079; 8,946,292 | ||
Attorneys | Mitchell G. Stockwell | ||
Firms | Connolly Gallagher LLP | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in Javelin Pharmaceuticals, Inc. v. Mylan Laboratories Limited
Details for Javelin Pharmaceuticals, Inc. v. Mylan Laboratories Limited (D. Del. 2016)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
2018-01-28 | 108 | the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,407,079 B1; 8,946,292 B2. (… 18 December 2017 1:16-cv-00224 830 Patent None District Court, D. Delaware | External link to document | |
2016-04-04 | 4 | the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,407,079 B1; 8,946,292 B2. (… 18 December 2017 1:16-cv-00224 830 Patent None District Court, D. Delaware | External link to document | |
2017-10-10 | 91 | Javelin asserts Orange Book-listed U.S. Patent Nos. 6,407,079 and 8,946,292, which general~l describe…quot;It ~s a bedrock principle of patent law that the claims of a patent define the inv~ntion to which…the data presented in the patent, the Court sees no indication in the patent or otherwise th~t the patentee…ultimate question of the proper construjon of a patent is a question oflaw. See Teva … I statutes and policies that inform patent law." Id. | External link to document | |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |